Big Pharma Is Betting On LLMs and Agents. What Would Count As Success?

In the latest news, Novo Nordisk has entered a collaboration with Anthropic aimed at speeding the discovery and development of new medicines. An initial project will test Anthropic's Claude Science on specific R&D workflows where the companies expect the greatest impact, and Novo also plans to use the models to strengthen software development so it can scale AI use across the company. Financial terms were not disclosed.